683 Capital Management »

Oncocyte Corporation shares owned by 683 Capital Management

Quarter-by-quarter ownership of Oncocyte Corporation (IMDX) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Oncocyte Corporation

Tip: Access up to 7 years of quarterly data

All positions including Oncocyte Corporation held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncocyte Corporation by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $579k 77k 7.50

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Oncocyte Corporation

Broadwood Capital
AWM Investment Company
Pura Vida Investments
Vanguard Group
Geode Capital Management
BlackRock
683 Capital Management
Millennium Management
Susquehanna International
Northern Trust
State Street Corporation
Jane Street
FNY Investment Advisers
Qube Research & Technologies
OMERS Administration Corporation

View all funds holding Oncocyte Corporation